ECE2009 Poster Presentations Thyroid (117 abstracts)
Propylthiouracil-induced anti-neutrophil cytoplasmic antibodies positive vasculitis
Marta Alves 1 , Celestino Neves 1 , Ângela Magalhães 1 , Ana Varela 1 , Fernanda Guerra 1 , Lídia Pereira-Monteiro 1 , Davide Carvalho 1 , Paulo Morais 2 , Ana Calistru 2 , Teresa Braudier 2 , A Mota 2 , J A Capela 3 , P S Couto 3 , R Ramalho 4 , J P Ramos 4 , C Guimarães 4 , J L Delgado 1 & J L Medina 1
1Endocrinology Department, S. João Hospital, Faculty of Medicine, University of Porto, Porto, Portugal; 2Dermatology Department, S. João Hospital, Faculty of Medicine, University of Porto, Porto, Portugal; 3Surgery Department, S. João Hospital, Faculty of Medicine, University of Porto, Porto, Portugal; 4Immunology Department, S. João Hospital, Faculty of Medicine, University of Porto, Porto, Portugal.
Introduction: Graves’ disease treatment with antithyroid drugs may be associated to several side effects. Vasculitis development is rare.
Clinical case: The authors present the history of a 41-year-old woman with Graves’ disease followed at endocrinology consultation since February 2004. Three years and a half after starting treatment with propilthiouracil (PTU), she developed eritematous and itching stains in the inferior limbs that spontaneously resolved in 3 days. Some weeks later, ecchymosis and a hematic blister appeared in the side face of the right leg. This lesion biopsy revealed ‘vascular thrombosis with epidermic necrolysis’. PTU was stopped and oral corticotherapy began. After corticoid withdrawal she developed a necrotic plate with blisters and an inflammatory halo in the right arm, purple plates in the right leg and bilateral malar eritema. Biopsy of the superior right member lesion showed ‘vasculitis with leucocitoclasia and thrombosis’. The analytical study was positive for anti-neutrophil cytoplasmic antibodies (ANCA), circulating immune complexes, anticardiolipin antibodies and antithyroid antibodies, and was negative for antinuclear antibodies, anti-dsDNA antibodies, anti-desmossoma antibodies, complement, rheumatoid factor, anti-ENA antibodies and anti-substance P antibodies. Treatment with PTU was interrupted. She was treated with prednisolone and non-steroidal anti-inflammatory drugs. She underwent total thyroidectomy. We observed progressive resolution of cutaneous lesions and normalization of ANCA levels.
Conclusion: PTU can induce ANCA positive vasculitis. Generally, therapeutic withdrawal leads to sintomatology resolution and drop of ANCA levels.
Article tools
My recent searches
My recently viewed abstracts
Authors
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more